Cochrane · systematic review · CD012802
Ab interno supraciliary microstent surgery for open‐angle glaucoma
Sandhu, A, Jayaram, H, Hu, K, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
Eyes and VisionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
5
No studies
2
Included studies
NR
No studies 2 · 28.6%Ungraded 0 · 0%Very low 0 · 0%Low 1 · 14.3%Moderate 3 · 42.9%High 1 · 14.3%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Phacoemulsification + supraciliary microstent surgery versus phacoemulsification alone for open‐angle glaucoma, at 24 months
Population: people with open‐angle glaucoma
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Proportion of participants who were medication‐free (not using eye‐drops)at 24 months (medium‐term) Phacoemulsification + supraciliary microstent surgery vs phacoemulsification alone | RR 1.27 [1.09, 1.49] | 1 study · 448 participants | Moderate Downgraded: risk of bias |
Mean change in unmedicated IOP24 months (medium‐term) Phacoemulsification + supraciliary microstent surgery vs phacoemulsification alone | no estimate extracted | 1 study · 448 participants | High |
Mean change in daily IOP‐lowering medicationsat 24 months (medium‐term) Phacoemulsification + supraciliary microstent surgery vs phacoemulsification alone | no estimate extracted | 1 study · 448 participants | Moderate Downgraded: risk of bias |
Proportion of participants who required further glaucoma surgeryat 24 months (medium‐term) Phacoemulsification + supraciliary microstent surgery vs phacoemulsification alone | RR 0.26 [0.07, 1.04] | 1 study · 505 participants | Low Downgraded: risk of bias, imprecision |
Mean change in health‐related quality of life Phacoemulsification + supraciliary microstent surgery vs phacoemulsification alone | no estimate extracted | NR | No studies |
Rate of visual field progression or proportion of participants whose field loss progressed Phacoemulsification + supraciliary microstent surgery vs phacoemulsification alone | no estimate extracted | NR | No studies |
Proportion of participants experiencing postoperative complicationsover 24 months (medium‐term) Phacoemulsification + supraciliary microstent surgery vs phacoemulsification alone | RR 1.1 [0.8, 1.4] | 1 study · 505 participants | Moderate Downgraded: risk of bias, imprecision |